While acknowledging that GLP-1 agonists have revolutionized the way diabetes and obesity are managed and play an important role in the care of many patients, the commentors ask, Will healthcare professionals prescribe these medications because they lead to a decreased risk of AMD
Vomiting, severe abdominal pain, or signs of pancreatitis (upper left abdominal pain, back pain, or elevated pancreatic enzymes) require immediate medical attention and warrant pausing further dose increases
Non-pharmacological approaches remain fundamental to weight management: Structured lifestyle interventions : NICE recommends multicomponent programmes incorporating dietary modification, increased physical activity, and behavioural strategies
says, Weight loss injections are a gamechanger for holistic weight health management, but they should be used safely, effectively, and within personalised programmes built around lifestyles
Eur J Med Chem Rep 5:100044 Cai HY, Yang D, Qiao J, Yang JT, Wang ZJ, Wu MN, Qi JS, Hlscher C (2021) A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimers Disease